Burger ed., Medicinal Chemistry 3rd ed., Wiley-Interscience, N.Y., 1970, pp. 694-697. |
Wodinsky et al., Chem. Abstracts, 92:121773n. |
Wampler et al., Absence of Cross-Resistance to Alkylating Agents in Cyclophosphamide-Resistant L1210 Leukemia, Europ. J. Cancer, vol. 14, pp. 977-982, 1978. |
Bardos et al., Synthesis of Potential Dual Antagonists III, Jour. of Pharmaceutical Sciences, vol. 54, No. 2, Feb., 1965. |
Chmielewicz et al., Synthesis and Chemotherapeutic Effects of Ethyl Bis-(2,2-Dimethyl)-Ethylenamido Phosphate. A Preliminary Report, Jour. of Pharmaceutical Sciences, vol. 56, No. 9, Sep. 1967. |
Wodinsky et al., Combined Therapy with an Aziridine Derivative NSC 200724 (AB182) and Radiation on an Experimental Leukemia. Int. J. Radiation Oncology Biol. Phys., vol. 4, pp. 1677-1680, 1979. |
Hsiao et al., Synthesis of New Bis(1-Aziridinyl) Phosphinate Alkylating Agents Containing O-Phenyl N-Phenylcarbamate Side Chains, Jour. of Med. Chem, vol. 16, p. 391, 1973. |
Lalka et al., Reactions of 2,2-Dimethyl-Aziridine-Type Alkylating Agents in Biological Systems I: Colorimetric Estimation and Stability in Physiological Media, Jour. of Pharmaceutical Sciences, vol. 62, No. 8, Aug., 1973. |
Bardos et al., Synthesis of Potential Dual Antagonists IV, Jour. of Pharmaceutical Sciences, Vol. 54, No. 3, Mar., 1965. |
Hsiao et al., Synthesis of Bis(Aziridinyl)Phosphinyl-N-Hydroxyurethane Derivatives as Antineoplastic Agents, Jour. of Medical Chemistry, vol. 18, p. 195, 1975. |
Bardos et al., Combination of Chemotherapy with Dual Antagonists and Radiotherapy in the Treatment of Neoplastic Disease, Journal of Surgical Oncology 3(4); pp. 431-441, 1971. |
Bardos et al., Structure-Activity Relationships of Alkylating Agents in Cancer Chemotherapy, Annals of The New York Academy of Sciences, vol. 163, Article 2, pp. 1006-1025, Oct. 3, 1969. |
Chmielwicz et al., Alternations of Some Macromolecular and Biochemical Properties of Calf Thymus DNA Caused by "Dual Antagonists" and Nitrogen Mustard, Cancer Research, 27, pp. 1248-1257, Jul. 1967. |
Munson et al., Preparation and Antitumor Activity of Tris(2,2-Dimethyl-1-Aziridinyl)Phosphine Oxide (TEPA-132), Cancer Chemotherapy Reports, vol. 51, No. 5. pp. 253-259, Sep. 1967. |
Bardos et al., Effects of Ring-C-Methyl Substituents on the Chemical and Biological Activities of Ethylenimine Type Alkylating Agents Int. Congress of Chemotherapy, Jun. 1967. |
Bardos, Antimetabolites, Molecular Design and Mode of Action, Topics in Current Chemistry, vol. 52, pp. 90 and 91 only, 1974. |
Lalka et al., Cyclophosphamide, 2,2-Dimethyl-Aziridines and Other Alkylating Agents as Inhibitors of Serum Cholinesterase, Biochemical Pharmacology, vol. 24, pp. 455-462, 1975. |
Lalka et al., Reactions of 2,2-Dimethyl-Aziridine-Type Alkylating Agents in Biological Systems II: Comparative Pharmacokinetics in DOGS, Jour., of Pharmaceutical Sciences, vol. 64, No. 2, Feb., 1975. |
Bardos et al., Chemical Mechanism of the Radiation Potentiating Effects of 2,2-Dimethylaziridine-Type Antitumor Agents, Int. J. Radiation Oncology Biol. Phys., vol. 4, pp. 1653-1656, 1979. |
Wampler et al., Radiation Potentiating Effect of Ethyl Bis(2,2-Dimethyl-1-Aziridinyl) Phosphinate (AB-163), Int. J. Radiation Oncology Biol. Phys., vol. 5, pp. 1681-1683, 1979. |
Hsiao et al., Synthesis of 5'-Thymidinyl Bis(1-Aziridinyl)Phosphinates as Antineoplastic Agents, Jour of Med. Chemistry, vol. 24, pp. 887-889, 1981. |
Zhdanov et al., Biologically Active Stable Radicals; XV.sup.1. Spinlabeled Alkyl Carbamate-N-Phosphonic Acid Aziridides, "Synthesis" pp. 269-271, 1979. |
Konieczny et al., Methods for the Preparation of Spin-Labeled Phosphorus Compounds and Applications of Some of Them to Phosphorylative Spin-Labeling, "Synthesis", Sep. 1981. |
Kimler et al., Development and Testing of New Hypoxic Cell Radiosensitizers, Radiology, vol. 33, pp. 515-517, 1979. |